Last A$0.50 AUD
Change Today 0.00 / 0.00%
Volume 0.0
As of 2:16 AM 04/30/14 All times are local (Market data is delayed by at least 15 minutes).

healthlinx ltd (HTX) Snapshot

Open
--
Previous Close
A$0.50
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
A$-0.95
Shares Outstanding
27.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HEALTHLINX LTD (HTX)

Related News

No related news articles were found.

healthlinx ltd (HTX) Related Businessweek News

No Related Businessweek News Found

healthlinx ltd (HTX) Details

HealthLinx Limited, a biomarker and diagnostic company, focuses on the development of novel blood based diagnostics for targeted diseases that have un-met market need. The company operates in three segments: Cryptomics, Diagnostics, and Peptide Research. It develops OvPlex, an ovarian cancer diagnostic targeting early detection of ovarian cancer in symptomatic women. HealthLinx Limited distributes its OvPlex primarily in Australia, Singapore, Malaysia, and the United Kingdom. The company is based in Melbourne, Australia.

healthlinx ltd (HTX) Top Compensated Officers

Secretary and Director
Total Annual Compensation: --
General Manager of Australian Operations
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

healthlinx ltd (HTX) Key Developments

HealthLinx Limited, Annual General Meeting, Jan 21, 2014

HealthLinx Limited, Annual General Meeting, Jan 21, 2014., at 10:30 AUS Eastern Standard Time. Location: Gardenia Room, Adina Apartment Hotel. Agenda: To consider the annual financial statements of the company for the financial year ended 30 June 2013 together with the declaration of the Directors, the Directors' report, the remuneration report and the auditor's report; to approve the adoption of the remuneration report, included within the Director's report, for the year ended 30 June 2013; to consider election of directors; to consider approval for the issue of shares to Gleneagle Securities Nominees Pty Ltd; to consider approval for the issue of shares to Doca Sponsors; to consider approval for the issue of shares to sponsor entities related to Directors - Trent Telford, Richard Revelins and Michael Quinert; to consider ratification of placement; to approve issue of shares to repay investor advance; to approve issue of shares on conversion of convertible notes; and to consider approval of additional 10% placement facility ­ Listing Rule 7.1A.

HealthLinx Limited Auditor Raises 'Going Concern' Doubt

HealthLinx Limited filed its Annual on Dec 10, 2013 for the period ending Jun 30, 2013. In this report its auditor, Grant Thornton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

HealthLinx Limited Reports Audited Consolidated Earnings Results for the Year Ended June 30, 2013

HealthLinx Limited reported audited consolidated earnings results for the year ended June 30, 2013. For the period, the company reported revenue of AUD 34,721 against AUD 190,445 for the same period last year. Total revenue and other income was AUD 50,493 against AUD 193,445 for the same period last year. Loss before income tax was AUD 4,365,297 against AUD 2,305,631 for the same period last year. Net loss was AUD 3,952,613 or 0.006 cents per basic and diluted share against AUD 1,967,572 or 0.08 cents per basic and diluted share for the same period last year. Net cash used in operating activities was AUD 661,153 against AUD 1,840,028 for the same period last year. Payments for intangibles were AUD 143,791 against AUD 412,890 for the same period last year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HTX:AU A$0.50 AUD 0.00

HTX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HTX.
View Industry Companies
 

Industry Analysis

HTX

Industry Average

Valuation HTX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales NM Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEALTHLINX LTD, please visit www.healthlinx.com.au. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.